Literature DB >> 2177224

Norwalk virus genome cloning and characterization.

J N Xi1, D Y Graham, K N Wang, M K Estes.   

Abstract

Major epidemic outbreaks of acute gastroenteritis result from infections with Norwalk or Norwalk-like viruses. Virus purified from stool specimens of volunteers experimentally infected with Norwalk virus was used to construct recombinant complementary DNA (cDNA) and derive clones representing most of the viral genome. The specificity of the clones was shown by their hybridization with post- (but not pre-) infection stool samples from volunteers infected with Norwalk virus and with purified Norwalk virus. A correlation was observed between the appearance of hybridization signals in stool samples and clinical symptoms of acute gastroenteritis in volunteers. Hybridization assays between overlapping clones, restriction enzyme analyses, and partial nucleotide sequence information of the clones indicated that Norwalk virus contains a single-stranded RNA genome of positive sense, with a polyadenylated tail at the 3' end and a size of at least 7.5 kilobases. A consensus amino acid sequence motif typical of viral RNA-dependent RNA polymerases was identified in one of the Norwalk virus clones. The availability of Norwalk-specific cDNA and the new sequence information of the viral genome should permit the development of sensitive diagnostic assays and studies of the molecular biology of the virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177224     DOI: 10.1126/science.2177224

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  166 in total

1.  Outbreaks of gastroenteritis caused by SRSVs from 1987 to 1992 in Kyushu, Japan: four outbreaks associated with oyster consumption.

Authors:  R Otsu
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

2.  Norwalk-like virus sequences in mineral waters: one-year monitoring of three brands.

Authors:  Christian Beuret; Dorothe Kohler; Andreas Baumgartner; Thomas M Lüthi
Journal:  Appl Environ Microbiol       Date:  2002-04       Impact factor: 4.792

3.  Virus-contaminated oysters: a three-month monitoring of oysters imported to Switzerland.

Authors:  Christian Beuret; Andreas Baumgartner; Jakob Schluep
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

4.  Study of Norwalk virus and Mexico virus infections at Ga-Rankuwa Hospital, Ga-Rankuwa, South Africa.

Authors:  T K Smit; A D Steele; I Peenze; X Jiang; M K Estes
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

5.  Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan.

Authors:  Kazushi Motomura; Masaru Yokoyama; Hirotaka Ode; Hiromi Nakamura; Hiromi Mori; Tadahito Kanda; Tomoichiro Oka; Kazuhiko Katayama; Mamoru Noda; Tomoyuki Tanaka; Naokazu Takeda; Hironori Sato
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

6.  Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein.

Authors:  X Jiang; M Wang; D Y Graham; M K Estes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

7.  Detection of Norwalk virus in stool by polymerase chain reaction.

Authors:  X Jiang; J Wang; D Y Graham; M K Estes
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

8.  Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Authors:  Jackie E Mahar; Nicole C Donker; Karin Bok; Gert H Talbo; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

9.  The carbohydrate moiety and high molecular weight carrier of histo-blood group antigens are both required for norovirus-receptor recognition.

Authors:  Pengwei Huang; Ardythe L Morrow; Xi Jiang
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

10.  The importance of intergenic recombination in norovirus GII.3 evolution.

Authors:  Jackie E Mahar; Karin Bok; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.